Subtype
Malignant Hepatobiliary Neoplasm
CI-CAN-00001136Explore in graph →
1,159 active trials17 approved drugs42 evidence items
- NCIt
- C8609
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001136Explore in graph →
Clinical trials
5,029 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (563)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02579616 | Study of Lenvatinib (E7080) in Unresectable Biliary Tract Cancer (BTC) Who Failed Gemcitabine-based Combination Chemotherapy | completed | Phase 2 | 29 | Eisai Co., Ltd.INDUSTRY | 1 | Dec 23, 2020 | clinicaltrials |
| NCT02082210 | A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer | completed | Phase 1 / Phase 2 | 97 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 19, 2020 | clinicaltrials |
| NCT02988440 | Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients | completed | Phase 1 | 20 | Novartis PharmaceuticalsINDUSTRY | 8 | Dec 19, 2020 | clinicaltrials |
| NCT03164382 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma | completed | Phase 3 | 262 | Sun Yat-sen UniversityOTHER | 1 | Dec 16, 2020 | clinicaltrials |
| NCT01906021 | Study of New Software Used During Ablations | completed | N/A | 13 | National Institutes of Health Clinical Center (CC)NIH | 1 | Dec 10, 2020 | clinicaltrials |
| NCT01687673 | Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma | completed | Phase 2 | 29 | University of California, San FranciscoOTHER | 1 | Dec 7, 2020 | clinicaltrials |
| NCT04652947 | MR Quality + Diagnostic Performance for CHC Diagnosis - Gadoxetic Acid, Gadoteric Acid and P03277 Comparison | completed | — | 30 | University Hospital, AngersOTHER_GOV | 0 | Dec 3, 2020 | clinicaltrials |
| NCT03251443 | A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma | completed | Phase 2 | 34 | Peking Union Medical College HospitalOTHER | 1 | Dec 2, 2020 | clinicaltrials |
| NCT03438435 | Fluorescence QRH-882260 Peptide Imaging in the Bile Duct | completed | Phase 1 | 1 | D. Kim Turgeon, MDOTHER | 1 | Dec 2, 2020 | clinicaltrials |
| NCT02239900 | Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors | completed | Phase 1 | 143 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT02265341 | Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions | completed | Phase 2 | 12 | Mayo ClinicOTHER | 1 | Nov 25, 2020 | clinicaltrials |
| NCT01198704 | Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC)(EFAPRE) | completed | — | 372 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 20, 2020 | clinicaltrials |
| NCT03231176 | Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer | completed | Phase 2 | 62 | ASLAN PharmaceuticalsOTHER | 1 | Nov 19, 2020 | clinicaltrials |
| NCT01828034 | First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma | completed | Phase 1 / Phase 2 | 42 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 17, 2020 | clinicaltrials |
| NCT01595243 | Effects of Telephone Consultations on Discharged Liver Cancer | completed | N/A | 254 | National Taiwan University HospitalOTHER | 1 | Nov 16, 2020 | clinicaltrials |
| NCT01264705 | Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer | completed | Phase 1 / Phase 2 | 47 | University of Texas Southwestern Medical CenterOTHER | 1 | Nov 12, 2020 | clinicaltrials |
| NCT02658019 | Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma | completed | Phase 2 | 29 | Lynn Feun, MDOTHER | 1 | Nov 12, 2020 | clinicaltrials |
| NCT01258998 | Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Nov 4, 2020 | clinicaltrials |
| NCT03380130 | A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC(NASIR-HCC) | completed | Phase 2 | 41 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Nov 4, 2020 | clinicaltrials |
| NCT03538028 | A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies | completed | Phase 1 | 22 | Incyte Biosciences International SàrlINDUSTRY | 1 | Oct 30, 2020 | clinicaltrials |
| NCT01835223 | Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 / Phase 2 | 33 | Roswell Park Cancer InstituteOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT01075321 | Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma | completed | Phase 1 / Phase 2 | 58 | Mayo ClinicOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT03007225 | Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients | completed | Phase 4 | 50 | Ain Shams UniversityOTHER | 0 | Oct 22, 2020 | clinicaltrials |
| NCT01844245 | Endobiliary RFA for Unresectable Malignant Biliary Strictures | completed | N/A | 174 | Bing HuOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT02288910 | Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver | completed | — | 7 | Rush University Medical CenterOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT01963429 | Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation for Recurrent/Residual HCC | completed | N/A | 144 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 6, 2020 | clinicaltrials |
| NCT04576572 | Comparison of Criteria for Liver Transplantation in Hepatocellular Carcinoma | completed | — | 424 | Inonu UniversityOTHER | 1 | Oct 6, 2020 | clinicaltrials |
| NCT01247337 | Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma | completed | Phase 2 | 56 | Dorte NielsenOTHER | 1 | Oct 5, 2020 | clinicaltrials |
| NCT02519075 | 11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE | completed | — | 14 | Istituto Clinico HumanitasOTHER | 1 | Oct 1, 2020 | clinicaltrials |
| NCT04568330 | Prevention of Hand-foot Skin Reaction | completed | N/A | 129 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 0 | Sep 29, 2020 | clinicaltrials |
| NCT04568512 | DNA Methylation Biomarker for Diagnosis of Cholangiocarcinoma in Patients With Bile Duct Stricture(DNA) | completed | N/A | 67 | Mahidol UniversityOTHER | 1 | Sep 29, 2020 | clinicaltrials |
| NCT02129829 | PROLIFICA - West African Treatment Cohort for Hepatitis B(WATCH) | completed | — | 1,079 | Imperial College LondonOTHER | 2 | Sep 28, 2020 | clinicaltrials |
| NCT04553458 | Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma | completed | — | 407 | Sohag UniversityOTHER | 0 | Sep 17, 2020 | clinicaltrials |
| NCT01938729 | Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma | completed | Phase 1 | 8 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 11, 2020 | clinicaltrials |
| NCT00132041 | Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis(ACRIN-6673) | completed | N/A | 51 | American College of Radiology Imaging NetworkNETWORK | 1 | Sep 10, 2020 | clinicaltrials |
| NCT03289533 | A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100) | completed | Phase 1 | 22 | PfizerINDUSTRY | 1 | Sep 4, 2020 | clinicaltrials |
| NCT00049322 | Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery | completed | Phase 2 | 30 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 1, 2020 | clinicaltrials |
| NCT01774344 | Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma(RESORCE) | completed | Phase 3 | 573 | BayerINDUSTRY | 21 | Aug 20, 2020 | clinicaltrials |
| NCT01935700 | Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma | completed | Phase 2 | 15 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Aug 19, 2020 | clinicaltrials |
| NCT02461966 | Evaluation of the Role of Aflatoxin as an Environmental Risk Factor Attributable to Liver Cancer in Nile Delta | completed | N/A | 300 | Sherief Abd-ElsalamOTHER | 1 | Aug 14, 2020 | clinicaltrials |
| NCT02069145 | Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer | completed | Phase 1 | 10 | OncoMed Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 11, 2020 | clinicaltrials |
| NCT03628651 | Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma | completed | — | 2,150 | Exact Sciences CorporationINDUSTRY | 7 | Aug 6, 2020 | clinicaltrials |
| NCT00005629 | Vaccine Therapy in Treating Patients With Liver Cancer | completed | Phase 1 / Phase 2 | 6 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT00022334 | Vaccine Therapy in Treating Patients With Liver Cancer | completed | Phase 1 / Phase 2 | 33 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT02753881 | Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer | completed | Phase 1 | 30 | Yale UniversityOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT02428855 | Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma | completed | Phase 2 | 8 | Massachusetts General HospitalOTHER | 1 | Jul 31, 2020 | clinicaltrials |
| NCT01099631 | IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread | completed | Phase 1 | 22 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT03140332 | Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib.(HCC-CTPerf) | completed | N/A | 2 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT02560779 | Trial of TRC105 and Sorafenib in Patients With HCC | completed | Phase 1 / Phase 2 | 27 | Tracon Pharmaceuticals Inc.INDUSTRY | 1 | Jul 17, 2020 | clinicaltrials |
Data updated 24 days agoSource updated Dec 23, 2020source: clinicaltrials